FDA approves breast reconstruction trial using human ADM
The FDA has granted an IDE for a trial investigating the FlexHD in breast reconstruction, despite the agency previously implicating a higher risk profile for the device when used off-label.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
